news
If you want to be kept up to date, you can subscribe to our
RSS-newsfeed or our Newsletter.
By using RSS you can stay on top of the news and information you
need without using your e-mail system and without repeatedly
checking multiple Web sites to see if they have been updated.
Please click on the RSS-icon to register.
May 1, 2012 - Productive workshop about reducing the use of laboratory animals
For many years now, the aim has been to use mouse embryonic stem
cells for research into the safety of substances during pregnancy.
To this end, a workshop was held in Leiden in which employees from
American and European authorities and experts from the medicines
industry and universities participated.
Read more »
April 27, 2012 - Informative meeting new pharmacovigilance legislation on 24 April 2012
On 24 april 2012 the Medicines Evaluation Board (MEB) organised
another informative meeting in Utrecht about the implications of
the new pharmacovigilance legislation. This meeting with 200
participants was primarily targeted at marketing authorisation
holders.
Read more »
April 25, 2012 - Presentation about Common European Submission Platform
On 19 April 2012, Stan van Belkum – employee at the Medicines
Evaluation Board (MEB) – gave a presentation about CESP for Regned.
Read more »
April 17, 2012 - CHMP bids farewell to its chairman with a standing ovation
The CHMP, the scientific committee of the European Medicines Agency
(EMA), in which the Medicines Evaluation Board (MEB) is
represented, said goodbye to its chairman Dr Eric Abadie with great
appreciation in London on 16 April 2012.
Read more »
April 13, 2012 - Results of the CORE study
The CORE study is a PhD research project carried out within the
Department of Clinical Pharmacology at the University Medical
Center Groningen (UMCG), in collaboration with the Medicines
Evaluation Board (MEB).
Read more »
March 28, 2012 - Look back at the Dies lecture Utrecht University
On Monday 26 March 2012, the University of Utrecht celebrated its
376th birthday – the Dies Natalis – in the Dom church. There was
great interest in this traditional gathering centred on the theme
of ‘Life Sciences’.
Read more »
March 26, 2012 - MEB chairman gives Dies lecture University Utrecht
Today – on 26 March 2012, the 376th Dies Natalis of the University
of Utrecht will take place. The theme for this year is Life
Sciences, one of the strategic goals of the university. MEB
chairman and professor of Pharmacoepidemiology, Prof Bert Leufkens,
is extremely honoured to give the Dies lecture.
Read more »
March 9, 2012 - Clinical practice central to the quarterly consultation between MEB and patient and consumer organisations
The quarterly consultation between the Medicines Evaluation Board
(MEB) and patient and consumer organisations took place on
Wednesday 7 March 2012. The discussion during the consultation
focused on clinical practice: what are the problems that patients
experience in using their medicines?
Read more »
February 29, 2012 - MEB has moved to Utrecht - new address as of 29 February 2012
The Medicines Evaluation Board (MEB) has moved to Utrecht. As of 29
February 2012 we have a new address.
Read more »
February 15, 2012 - Public MEB reports partially updated
The Medicines Evaluation Board (MEB) has updated the public reports
for MEB Meetings 721 to 730.
Read more »
February 3, 2012 - MEB signs new code to prevent being influenced by a conflict of interests
The Medicines Evaluation Board (MEB) has signed a Code together
with more than thirty organisations in order to prevent a possible
conflict of interests. For example, the interests of experts who
form part of scientific and advice committees are disclosed via the
code in order to prevent a conflict of interests and thereby
improper influences.
Read more »
January 19, 2012 - The MEB is moving to Utrecht this year
The MEB, which currently has 6 offices throughout the country,
moves to one central location in Utrecht on 29 February
2012. The MEB remains connected to the University Medical
Centre Groningen and the University Medical Centre St. Radboud in
Nijmegen. These two institutions can be reached via the general
telephone number and postal address.
Read more »
January 5, 2012 - Common European Submission Platform: Extended Proof of Concept
Under the remit of the Heads of Medicines Agency (HMA), a
group of Agencies and Industry Representatives have been
working to investigate the feasibility for the development of
a Common European Submission Platform (CESP). A Proof of Concept
was run during September and October 2011 and following its
success the next steps for CESP were agreed at the Heads of
Medicines Agency (HMA) meeting in November 2011.
Read more »